Les métastases cutanées des cancers profonds, Presse Med, vol.22, pp.631-636, 1993. ,
Histopathologic aspects of cutaneous metastatic disease, Journal of the American Academy of Dermatology, vol.33, issue.4, pp.649-657, 1995. ,
DOI : 10.1016/0190-9622(95)91288-6
Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases, Modern Pathology, vol.13, issue.9, pp.962-972, 2000. ,
DOI : 10.1038/modpathol.3880175
Cytokeratins 7 and 20: aid in tumor typing, Ann Pathol, vol.18, pp.103-109, 1998. ,
The <i>Cdx-1</i> and <i>Cdx-2</i> homeobox genes in the intestine, Biochemistry and Cell Biology, vol.76, issue.6, pp.957-969, 1998. ,
DOI : 10.1139/bcb-76-6-957
gene, Annals of Human Genetics, vol.61, issue.5, pp.393-400, 1997. ,
DOI : 10.1046/j.1469-1809.1997.6150393.x
CDX-2, a New Marker for Adenocarcinoma of Gastrointestinal Origin, Advances in Anatomic Pathology, vol.11, issue.2, pp.101-105, 2004. ,
DOI : 10.1097/00125480-200403000-00004
CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin, The American Journal of Surgical Pathology, vol.27, issue.3, pp.303-310, 2003. ,
DOI : 10.1097/00000478-200303000-00003
CDX-2 Homeobox Gene Expression Is a Reliable Marker of Colorectal Adenocarcinoma Metastases to the Lungs, The American Journal of Surgical Pathology, vol.27, issue.2, pp.141-149, 2003. ,
DOI : 10.1097/00000478-200302000-00001
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas, Modern Pathology, vol.176, issue.11, pp.1392-1399, 2004. ,
DOI : 10.1038/modpathol.3800205
Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the Colon, The American Journal of Pathology, vol.159, issue.6, pp.2239-2248, 2001. ,
DOI : 10.1016/S0002-9440(10)63074-X
CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma, Applied Immunohistochemistry & Molecular Morphology, vol.17, issue.3, pp.196-201, 2009. ,
DOI : 10.1097/PAI.0b013e31819268f2
CDX-2 Expression Is a Common Event in Primary Intestinal-type Endocervical Adenocarcinoma, American Journal of Clinical Pathology, vol.132, issue.4, pp.531-538, 2004. ,
DOI : 10.1309/AJCP7E5ASGOENPFP
Usefulness of CDX2 in the diagnosis of extramammary Paget disease associated with malignancies of intestinal type, British Journal of Dermatology, vol.119, issue.3, pp.677-679, 2005. ,
DOI : 10.1111/j.1365-2133.2005.06798.x
Potential Diagnostic Utility of CDX-2 Immunophenotyping in Extramammary Paget??s Disease, Applied Immunohistochemistry & Molecular Morphology, vol.13, issue.4, pp.342-346, 2005. ,
DOI : 10.1097/01.pai.0000163989.12896.d2
Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer, Clinical Cancer Research, vol.15, issue.14, pp.4665-4673, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-0401
The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas, Clinical Cancer Research, vol.11, issue.24, pp.8549-8556, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-1624
CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48 22 Mazziotta R, Borczuk A, Powell CA and Mansukhani M: CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall, Oncogene Appl Immmunohistochem Mol Morphol, vol.25, issue.13, pp.2264-2272, 2005. ,
Mammary and extramammary Paget's disease, Journal of the European Academy of Dermatology and Venereology, vol.33, issue.0, pp.581-590, 2007. ,
DOI : 10.1111/j.1365-2133.2005.06865.x